American Academy of Neurology (AAN 2025)

San Diego, CA
|
April 5 - 9, 2025
Focus: 
Myasthenia Gravis (MG)
Location: 
N/A

Publication Presented

Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results of a Phase 3 Study